These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32086362)

  • 41. Advances in the surgical management of ovarian cancer.
    Horowitz NS; Duska LR
    J Reprod Med; 2005 Jun; 50(6):454-66. PubMed ID: 16050570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.
    Colombo N; Sessa C; du Bois A; Ledermann J; McCluggage WG; McNeish I; Morice P; Pignata S; Ray-Coquard I; Vergote I; Baert T; Belaroussi I; Dashora A; Olbrecht S; Planchamp F; Querleu D;
    Ann Oncol; 2019 May; 30(5):672-705. PubMed ID: 31046081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery.
    Grabowski JP; Harter P; Buhrmann C; Lorenz D; Hils R; Kommoss S; Traut A; du Bois A
    Surg Oncol; 2012 Mar; 21(1):31-5. PubMed ID: 20875732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How to improve training in bowel surgery for gynecological oncologists-experience from a single center in the United kingdom.
    Burbos N; Abu-Freij M; Kapur S; Crocker SG; Duncan TJ; Nieto JJ
    Int J Gynecol Cancer; 2011 Dec; 21(9):1692-4. PubMed ID: 21705910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytoreductive surgery for ovarian cancer: quality assessment.
    Brand AH; DiSilvestro PA; Sehouli J; Berek JS
    Ann Oncol; 2017 Nov; 28(suppl_8):viii25-viii29. PubMed ID: 29232471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient Support Groups Identifying Clinical Equipoise in UK Gynaecological Oncology Surgeons as the Basis for Trials in Ultraradical Surgery for Advanced Ovarian Cancer.
    Naik R; Bayne L; Founta C; Kehoe S; Rustin G; Fotopoulou C
    Int J Gynecol Cancer; 2016 Jan; 26(1):91-4. PubMed ID: 26512783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced recovery after surgery (ERAS®) in gynecologic oncology - Practical considerations for program development.
    Nelson G; Dowdy SC; Lasala J; Mena G; Bakkum-Gamez J; Meyer LA; Iniesta MD; Ramirez PT
    Gynecol Oncol; 2017 Dec; 147(3):617-620. PubMed ID: 28947172
    [No Abstract]   [Full Text] [Related]  

  • 48. Primary surgical cytoreduction in advanced ovarian cancer: An outcome analysis within the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.
    Greggi S; Falcone F; Carputo R; Raspagliesi F; Scaffa C; Laurelli G; Giorda G; Di Vagno G; Petruzzelli F; Cormio G; Marinaccio M; Pignata S
    Gynecol Oncol; 2016 Mar; 140(3):425-9. PubMed ID: 26825616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force.
    Ramirez PT; Adams S; Boggess JF; Burke WM; Frumovitz MM; Gardner GJ; Havrilesky LJ; Holloway R; Lowe MP; Magrina JF; Moore DH; Soliman PT; Yap S
    Gynecol Oncol; 2012 Feb; 124(2):180-4. PubMed ID: 22079679
    [No Abstract]   [Full Text] [Related]  

  • 51. How to improve cytoreductive surgery for advanced ovarian cancer and talk about it in a common language.
    Sammartino P; Biacchi D; Di Giorgio A
    Gynecol Oncol; 2012 Nov; 127(2):433-4; author reply 434. PubMed ID: 22850413
    [No Abstract]   [Full Text] [Related]  

  • 52. Laparoscopic management of gynaecological cancer in pregnancy.
    Berretta R; Rolla M; Ceccaroni M; Benassi G; Modena AB; Nardelli GB
    J Obstet Gynaecol; 2010 Apr; 30(3):319-21. PubMed ID: 20373947
    [No Abstract]   [Full Text] [Related]  

  • 53. Quality control in ovarian cancer surgery.
    Aletti GD; Peiretti M
    Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():96-107. PubMed ID: 27806912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EORTC-GCG process quality indicators for ovarian cancer surgery.
    Verleye L; Ottevanger PB; van der Graaf W; Reed NS; Vergote I;
    Eur J Cancer; 2009 Mar; 45(4):517-26. PubMed ID: 19013789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The limits of aggressive surgical cytoreduction.
    Levine DA
    Gynecol Oncol; 2018 Aug; 150(2):205-206. PubMed ID: 30025830
    [No Abstract]   [Full Text] [Related]  

  • 56. A statement for extensive primary cytoreductive surgery in advanced ovarian cancer.
    Pomel C; Barton DP; McNeish I; Shepherd J
    BJOG; 2008 Jun; 115(7):808-10. PubMed ID: 18485155
    [No Abstract]   [Full Text] [Related]  

  • 57. The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations.
    Cohn DE; Ko E; Meyer LA; Wright JD; Temkin SM; Foote J; Jones NL; Havrilesky LJ
    Gynecol Oncol; 2017 Apr; 145(1):185-191. PubMed ID: 28258763
    [No Abstract]   [Full Text] [Related]  

  • 58. Re: A statement for extensive primary cytoreductive surgery in advanced ovarian cancer.
    Nevin J; Luesley D
    BJOG; 2008 Nov; 115(12):1586; author reply 1586-7. PubMed ID: 19036008
    [No Abstract]   [Full Text] [Related]  

  • 59. Advanced cytoreductive surgery: Asia Pacific perspective.
    Crandon AJ; Obermair A
    Gynecol Oncol; 2009 Aug; 114(2 Suppl):S15-21. PubMed ID: 19573700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update.
    Nelson G; Bakkum-Gamez J; Kalogera E; Glaser G; Altman A; Meyer LA; Taylor JS; Iniesta M; Lasala J; Mena G; Scott M; Gillis C; Elias K; Wijk L; Huang J; Nygren J; Ljungqvist O; Ramirez PT; Dowdy SC
    Int J Gynecol Cancer; 2019 May; 29(4):651-668. PubMed ID: 30877144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.